Market overview
The global neurorehabilitation technology market is worth USD 3.4 bn in 2026 and is forecast to reach USD 8.0 bn by 2036, growing at a 9.0% CAGR. United States is the largest country market and Robotic therapy is the largest by technology segment.
| Scope | Devices and software for recovering movement, speech and cognition after brain and spinal injury: rehabilitation robots, functional electrical and magnetic stimulation, virtual reality training, assistive mobility and tele-rehabilitation platforms. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 3.1 bn |
| Value 2026 | USD 3.4 bn |
| Value 2036 | USD 8.0 bn |
| CAGR 2026-2036 | 9.0% |
| Volume 2026 | 104 thousand units |
| Volume 2036 | 245 thousand units |
| Average price 2026 | USD 32,630 per unit |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Neurorehabilitation Technology market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 3.4 bn |
| 2027 | USD 3.7 bn |
| 2028 | USD 4.0 bn |
| 2029 | USD 4.4 bn |
| 2030 | USD 4.8 bn |
| 2031 | USD 5.2 bn |
| 2032 | USD 5.7 bn |
| 2033 | USD 6.2 bn |
| 2034 | USD 6.7 bn |
| 2035 | USD 7.3 bn |
| 2036 | USD 8.0 bn |
Neurorehabilitation Technology market segmentation
By technology
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Robotic therapy | 30.0% | 27.8% | USD 1.0 bn | 8.2% |
| Neurostimulation | 26.0% | 24.1% | USD 879 mn | 8.2% |
| Assistive and mobility devices | 18.0% | 15.2% | USD 608 mn | 7.2% |
| Virtual reality and gaming | 14.0% | 17.0% | USD 473 mn | 11.1% |
| Sensor and tele-rehabilitation platforms | 12.0% | 15.9% | USD 405 mn | 12.1% |
By condition
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Stroke | 46.0% | 46.3% | USD 1.6 bn | 9.1% |
| Spinal cord injury | 16.0% | 15.4% | USD 541 mn | 8.6% |
| Parkinson's disease and multiple sclerosis | 16.0% | 16.9% | USD 541 mn | 9.6% |
| Traumatic brain injury | 14.0% | 14.1% | USD 473 mn | 9.1% |
| Cerebral palsy | 8.0% | 7.3% | USD 270 mn | 8.1% |
By patient interaction
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Robotic-assisted systems | 30.0% | 32.0% | USD 1.0 bn | 9.7% |
| Exoskeletons | 18.0% | 20.0% | USD 608 mn | 10.2% |
| Virtual reality systems | 16.0% | 20.0% | USD 541 mn | 11.5% |
| Functional electrical stimulation | 14.0% | 13.0% | USD 473 mn | 8.2% |
| Brain stimulation devices | 22.0% | 15.0% | USD 743 mn | 4.9% |
By setting
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Rehabilitation centers | 42.0% | 38.0% | USD 1.4 bn | 7.9% |
| Hospitals | 34.0% | 32.0% | USD 1.1 bn | 8.3% |
| Home-based | 24.0% | 30.0% | USD 811 mn | 11.5% |
By component
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Hardware | 60.0% | 52.0% | USD 2.0 bn | 7.5% |
| Software and content | 22.0% | 26.0% | USD 743 mn | 10.8% |
| Services | 18.0% | 22.0% | USD 608 mn | 11.2% |
Top 25 countries for neurorehabilitation technology by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 83.0% of 2026 revenue and the 25 countries below together hold 95.6%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 1.0 bn | 30.0% | USD 2.4 bn | 9.0% |
| 2 | China | USD 473 mn | 14.0% | USD 1.3 bn | 10.9% |
| 3 | Japan | USD 304 mn | 9.0% | USD 624 mn | 7.5% |
| 4 | Germany | USD 270 mn | 8.0% | USD 584 mn | 8.0% |
| 5 | South Korea | USD 169 mn | 5.0% | USD 440 mn | 10.0% |
| 6 | France | USD 135 mn | 4.0% | USD 288 mn | 7.9% |
| 7 | Italy | USD 135 mn | 4.0% | USD 280 mn | 7.5% |
| 8 | United Kingdom | USD 135 mn | 4.0% | USD 304 mn | 8.4% |
| 9 | Spain | USD 84 mn | 2.5% | USD 184 mn | 8.1% |
| 10 | Brazil | USD 84 mn | 2.5% | USD 216 mn | 9.8% |
| 11 | Netherlands | USD 82 mn | 2.4% | USD 202 mn | 9.4% |
| 12 | Australia | USD 66 mn | 1.9% | USD 154 mn | 8.8% |
| 13 | Canada | USD 52 mn | 1.5% | USD 121 mn | 8.8% |
| 14 | Switzerland | USD 46 mn | 1.4% | USD 107 mn | 8.8% |
| 15 | Belgium | USD 36 mn | 1.1% | USD 85 mn | 8.9% |
| 16 | Sweden | USD 29 mn | 0.8% | USD 66 mn | 8.7% |
| 17 | Austria | USD 23 mn | 0.7% | USD 54 mn | 8.8% |
| 18 | Denmark | USD 21 mn | 0.6% | USD 48 mn | 8.8% |
| 19 | Mexico | USD 18 mn | 0.5% | USD 41 mn | 8.8% |
| 20 | Turkey | USD 14 mn | 0.4% | USD 31 mn | 8.7% |
| 21 | Poland | USD 11 mn | 0.3% | USD 26 mn | 8.7% |
| 22 | Israel | USD 9.1 mn | 0.3% | USD 21 mn | 8.6% |
| 23 | Taiwan | USD 8.1 mn | 0.2% | USD 18 mn | 8.5% |
| 24 | Saudi Arabia | USD 6.1 mn | 0.2% | USD 14 mn | 9.0% |
| 25 | Singapore | USD 4.7 mn | 0.1% | USD 11 mn | 9.0% |
| Rest of world | USD 149 mn | 4.4% | USD 352 mn | 8.9% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- Enovis
- Ottobock
- Bioventus
- Ekso Bionics
- Hocoma
Group 2: Regional and specialist players
- Tyromotion
- Fourier Intelligence
- Cyberdyne
- Bionik Laboratories
- Myomo
- Wandercraft
- ReWalk Robotics
Group 3: Emerging and niche players
- Neofect
- Motus Nova
- Saebo
- MindMaze
- BrainCo
- Reha Technology
- Flint Rehab
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the neurorehabilitation technology market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 9.0% is calculated from the resulting values.
The market is divided by technology, by condition, by patient interaction, by setting, by component. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the neurorehabilitation technology market?
The global neurorehabilitation technology market is estimated at USD 3.1 bn in 2025 and USD 3.4 bn in 2026.
How fast will the neurorehabilitation technology market grow?
It is forecast to reach USD 8.0 bn by 2036, a compound annual growth rate of 9.0% from 2026, an increase of USD 4.6 bn.
Which country is the largest market for neurorehabilitation technology?
United States is the largest market by revenue at USD 1.0 bn in 2026, 30.0% of the global total. The three largest countries together hold 53.0%.
Which country is growing fastest?
Among the ten largest markets, China is growing fastest at 10.9% a year from 2026 to 2036.
Which neurorehabilitation technology segment is largest?
In the by technology split, Robotic therapy is the largest segment with 30.0% of 2026 revenue.
Who are the leading neurorehabilitation technology companies?
Global leaders include Enovis, Ottobock, Bioventus, Ekso Bionics.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- CapsuleUSD 3.4 bn · 6.5% CAGR
- Healthcare Provider Workflow OptimizationUSD 3.4 bn · 10.5% CAGR
- ImmunohistochemistryUSD 3.5 bn · 8.0% CAGR
- BiobankingUSD 3.2 bn · 8.5% CAGR
- Lyophilization EquipmentUSD 3.1 bn · 7.6% CAGR
- AutoinjectorUSD 3.7 bn · 10.0% CAGR
- Pharmaceutical SerializationUSD 3.7 bn · 9.0% CAGR
- Continuous Positive Airway Pressure (CPAP)USD 3.1 bn · 6.5% CAGR
← Neuromodulation Closed-Loop Brain-Computer Interfaces Neurosurgery & Spine Robots →